FLU-v
AssetAlso influenza vaccine, Influenza vaccine (split virion, inactivated), ZFA02, 4Fluart ID
Inactivated influenza virus vaccine inducing protective antibody responses
- Stage
- Phase 3
- Modality
- Vaccine
- Target
- Inflammation
- 9
- Indications
- 89
- Trials
- 8
- Developers
Indications
9Influenza
Phase 3, Completed, NCT01404182, clinicaltrials.gov, 7 Oct 2026
Influenza immunization
Phase 3, Completed, NCT04024228, clinicaltrials.gov, 7 Oct 2026
Mumps
Phase 3, Unknown, NCT06208683, clinicaltrials.gov, 7 Oct 2026
6 more
In the full profile
- Targets and what it contains2
- Owner and partners8
- Trials89
- Evidence for its targets2
- Competitors7
- Signals4
Every asset’s record: target, stage, trials and the evidence behind it.
Updated 8 Oct 2026, 23 sources